Antrodia camphorata grown on germinated brown rice inhibits HT-29 human colon carcinoma proliferation through inducing G0/G1 phase arrest and apoptosis by targeting the β-catenin signaling

Journal of Medicinal Food

Volumn 16, Issue 8, 2013, Pages 681-691

  Park, Dong Ki ^a   Lim, Yoong Ho ^a   Park, Hye Jin ^a  

^a Konkuk University   (South Korea)

Author keywords

Antrodia camphorata grown on germinated brown rice (CBR); apoptosis; b catenin; colon cancer; G0 G1 cell cycle arrest

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTINEOPLASTIC AGENT; ANTRODIA CAMPHORATA EXTRACT; BETA CATENIN; BUTANOL; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; HEXANE; LIPOCORTIN 5; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTRODIA CAMPHORATA; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CULTURE; CELL CYCLE PROGRESSION; CELL POPULATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; G1 PHASE CELL CYCLE CHECKPOINT; GERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; RICE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTRODIA; APOPTOSIS; BETA CATENIN; BIOLOGICAL FACTORS; CELL PROLIFERATION; COLONIC NEOPLASMS; G1 PHASE CELL CYCLE CHECKPOINTS; GERMINATION; HT29 CELLS; HUMANS; ORYZA SATIVA; SIGNAL TRANSDUCTION;

EID: 84883000230     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2605     Document Type: Article

References (55)

1. Potter JD, Slattery ML, Bostick RM, Gapstur SM: Colon cancer: A review of the epidemiology. Epidemiol Rev 1993;15:499-545.
2. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
4. Panchal RG: Novel therapeutic strategies to selectively kill cancer cells. Biochem Pharmacol 1998;55:247-252.
5. Takayama T, Katsuki S, Takahashi Y, et al.: Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339:1277-1284.
6. Segditsas S, Tomlinson I: Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006;25:7531-7537.
7. Liu FS, Yang PY, Hu DN, Huang YW, Chen MJ: Antrodia camphorata induces apoptosis and enhances the cytotoxic effect of paclitaxel in human ovarian cancer cells. Int J Gynecol Cancer 2011;21:1172-1179.
8. Brabletz T, Jung A, Reu S, et al.: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001;98: 10356-10361.
9. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL: Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 2004;10:1401-1408.
10. Hwang JH, Kim JY, Cha MR, Park HR: Effect of methanolic extract from silkworm droppings on proliferation and caspase activity in HT-29 human colon cancer cells. J Med Food 2007;10:467-472.
11. Ao ZH, Xu ZH, Lu ZM, Xu HY, Zhang XM, Dou WF: Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. J Ethnopharmacol 2009;121:194-212.
12. Chen KC, Peng CC, Peng RY, et al.: Unique formosan mushroom Antrodia camphorata differentially inhibits androgenresponsive LNCaP and -independent PC-3 prostate cancer cells. Nutr Cancer 2007;57:111-121.
13. Chiou JF, Wu AT, Wang WT, et al.: A preclinical evaluation of Antrodia camphorata alcohol extracts in the treatment of nonsmall cell lung cancer using non-invasive molecular imaging. Evid Based Complement Alternat Med 2011;2011:914561.
14. Du YC, Wu TY, Chang FR, et al.: Chemical profiling of the cytotoxic triterpenoid-concentrating fraction and characterization of ergostane stereo-isomer ingredients from Antrodia camphorata. J Pharm Biomed Anal 2012;58:182-192.
15. Geethangili M, Tzeng YM: Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evid Based Complement Alternat Med 2011;2011:212641.
16. Ho CM, Huang CC, Huang CJ, et al.: Effects of Antrodia camphorata on viability, apoptosis, and [Ca2 + ]i in PC3 human prostate cancer cells. Chin J Physiol 2008;51:78-84.
17. Hseu YC, Chang WC, Hseu YT, et al.: Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes. Life Sci 2002;71:469-482.
18. Hseu YC, Chen SC, Chen HC, Liao JW, Yang HL: Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo. Food Chem Toxicol 2008;46:2680-2688.
19. Hseu YC, Chen SC, Tsai PC, et al.: Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food Chem Toxicol 2007;45:1107-1115.
20. Hseu YC, Yang HL, Lai YC, Lin JG, Chen GW, Chang YH: Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells. Nutr Cancer 2004;48: 189-197.
21. Hsieh YC, Rao YK, Wu CC, et al.: Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway. Chem Res Toxicol 2010;23:1256-1267.
22. Huang CC, Cheng HH, Wang JL, et al.: Effects of Antrodia camphorata extracts on the viability, apoptosis, [Ca2 + ]i, and MAPKs phosphorylation of OC2 human oral cancer cells. Chin J Physiol 2009;52:128-135.
23. Huang NK, Cheng JJ, Lai WL, Lu MK: Antrodia camphorata prevents rat pheochromocytoma cells from serum deprivationinduced apoptosis. FEMS Microbiol Lett 2005;244:213-219.
24. Li SL, Huang ZN, Hsieh HH, et al.: The augmented anti-tumor effects of Antrodia camphorata co-fermented with Chinese medicinal herb in human hepatoma cells. Am J Chin Med 2009;37:771-783.
25. Lien HM, Kuo PT, Huang CL, et al.: Study of the anti-proliferative activity of 5-substituted 4,7-dimethoxy-1,3-benzodioxole derivatives of SY-1 from Antrodia camphorata on human COLO 205 colon cancer cells. Evid Based Complement Alternat Med 2011;2011:450529.
26. Lin SY, Sheen LY, Chiang BH, et al.: Dietary effect of Antrodia camphorate extracts on immune responses in WEHI-3 leukemia BALB/c mice. Nutr Cancer 2010;62:593-600.
27. Liu JJ, Huang TS, Hsu ML, et al.: Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action. Toxicol Appl Pharmacol 2004; 201:186-193.
28. Lu MC, Du YC, Chuu JJ, et al.: Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. Arch Toxicol 2009;83:121-129.
29. Rao YK, Wu AT, Geethangili M, et al.: Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells. Chem Res Toxicol 2011;24: 238-245.
30. Tsai WC, Rao YK, Lin SS, et al.: Methylantcinate A induces tumor specific growth inhibition in oral cancer cells via Baxmediated mitochondrial apoptotic pathway. Bioorg Med Chem Lett 2010;20:6145-6148.
31. Park HJ, Choi SY, Hong SM, Hwang SG, Park DK: The ethyl acetate extract of Phellinus linteus grown on germinated brown rice induces G(0)/G(1) cell cycle arrest and apoptosis in human colon carcinoma HT29 cells. Phytother Res 24:1019-1026.
32. Oh JY, Choi WS, Lee CH, Park HJ: The ethyl acetate extract of Cordyceps militaris inhibits IgE-mediated allergic responses in mast cells and passive cutaneous anaphylaxis reaction in mice. J Ethnopharmacol 2011;135:422-429.
33. Han ES, Oh JY, Park HJ: Cordyceps militaris extract suppresses dextran sodium sulfate-induced acute colitis in mice and production of inflammatory mediators from macrophages and mast cells. J Ethnopharmacol 2011;134:703-710.
34. Mayol X, Garriga J, Grana X: Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 1995;11:801-808.
35. Freemantle SJ, Liu X, Feng Q, et al.: Cyclin degradation for cancer therapy and chemoprevention. J Cell Biochem 2007;102: 869-877.
36. Kim ND, Im E, Yoo YH, Choi YH: Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acids. Current Cancer Drug Targets 2006;6:681-689.
37. Emami KH, Nguyen C, Ma H, et al.: A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA 2004;101:12682-12687.
38. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
39. Jedinak A, Thyagarajan-Sahu A, Jiang J, Sliva D: Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ss-catenin signaling. Int J Oncol 2011;38:761-767.
40. Isbell G, Levin B: Ulcerative colitis and colon cancer. Gastroenterol Clin North Am 1988;17:773-791.
41. Niewolik D, Vojtesek B, Kovarik J: P53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence. Oncogene 1995;10:881-890.
42. Howell AS, Lew DJ: Morphogenesis and the cell cycle. Genetics 2012;190:51-77.
43. Harada H, Yamashita U, Kurihara H, Fukushi E, Kawabata J, Kamei Y: Antitumor activity of palmitic acid found as a selective cytotoxic substance in a marine red alga. Anticancer Res 2002;22:2587-2590.
44. Bartkova J, Lukas J, Strauss M, Bartek J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994;58:568-573.
45. Yan YX, Nakagawa H, Lee MH, Rustgi AK: Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. J Biol Chem 1997;272: 33181-33190.
46. Singh RP, Dhanalakshmi S, Agarwal R: Phytochemicals as cell cycle modulators-a less toxic approach in halting human cancers. Cell Cycle 2002;1:156-161.
47. Gupta S, Kass GE, Szegezdi E, Joseph B: The mitochondrial death pathway: A promising therapeutic target in diseases. J Cell Mol Med 2009;13:1004-1033.
48. Vermeulen K, Van Bockstaele DR, Berneman ZN: Apoptosis: Mechanisms and relevance in cancer. Ann Hematol 2005;84:627-639.
49. Suh Y, Afaq F, Johnson JJ, Mukhtar H: A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB- signaling pathways. Carcinogenesis 2009;30:300-307.
50. Stambolic V, Woodgett JR: Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 1994;303:701-704.
51. Palmer HG, Gonzalez-Sancho JM, Espada J, et al.: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001;154:369-387.
52. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-193.
53. Meng Q, Qi M, Chen DZ, et al.: Suppression of breast cancer invasion and migration by indole-3-carbinol: Associated with upregulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med (Berl) 2000;78:155-165.
54. Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T: Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 2004;67: 2005-2011.
55. Yang D, Yaguchi T, Yamamoto H, Nishizaki T: Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation. Biochem Pharmacol 2007;73:1665-1675.